HomeBIOBV • HEL
add
Biohit Oyj
Previous close
€2.30
Day range
€2.25 - €2.35
Year range
€1.80 - €2.65
Market cap
28.07M EUR
Avg Volume
9.27K
P/E ratio
-
Dividend yield
-
Primary exchange
HEL
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 3.70M | 13.85% |
Operating expense | 1.65M | 6.45% |
Net income | 600.00K | -14.29% |
Net profit margin | 16.22 | -24.70% |
Earnings per share | — | — |
EBITDA | 750.00K | -6.25% |
Effective tax rate | 14.29% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.00M | -10.71% |
Total assets | 14.20M | 13.60% |
Total liabilities | 3.40M | -2.86% |
Total equity | 10.80M | — |
Shares outstanding | 15.17M | — |
Price to book | 3.24 | — |
Return on assets | 11.44% | — |
Return on capital | 14.13% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 600.00K | -14.29% |
Cash from operations | -750.00K | -275.00% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | -50.00K | 0.00% |
Net change in cash | -750.00K | -66.67% |
Free cash flow | 393.75K | -17.11% |
About
Biohit Oyj is a Finnish company which develops, manufactures, and markets biotech and diagnostics products for use in research and health care. Wikipedia
Founded
1988
Website
Employees
47
